Clinical Trials List
Protocol NumberW00090GE203
Completed
2022-01-01 - 2025-02-28
Phase II
Terminated2
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chao-Hua Chiu Division of Hematology & Oncology
- Chia-I Shen Division of Hematology & Oncology
- Yung-Hung Luo Division of Hematology & Oncology
- Hsu-ching Huang Division of Hematology & Oncology
- Chi-Lu Chiang Division of Hematology & Oncology
- 趙恒勝 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
55 participants
